Abstract
Behcet’s disease is an inflammatory disorder of unknown cause, characterized by recurrent oral aphthous ulcers, genital ulcers, uveitis, and skin lesions. All these common manifestations are self-limiting except for the ocular attacks. The objective of the present study is to report the efficacy of pentoxifylline for ocular involvement in Behcet’s disease. We report a patient with ocular involvement secondary to Behcet’s disease which was corticosteroid dependent and refractory to azathioprine treatment. Pentoxifylline was added with amelioration of inflammation. Pentoxifylline may be a useful treatment option in patients with Behcet’s disease, where other immunosuppressives have failed or are contra-indicated.
References
Kaklamani VG, Vaiopoulos G, Kaklamanis PH (1998) Behçet’s disease. Semin Arthritis Rheum 27:197–217
Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behcet’s disease. N Engl J Med 341(17):1284–1291
Nussenblatt RB (1997) Uveitis in Behçet’s disease. Int Rev Immunol 14:67–79
Kaklamani VG, Kaklamanis PG (2001) Treatment of Behçet’s disease—an update. Semin Arthritis Rheum 30:299–312
Yazici H, Barnes CG (1991) Practical treatment recommendations for pharmacotherapy of Behçet’s syndrome. Drugs 42:796–804
Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A et al (2009) Management of Behçet disease: a systematic literature review for the European League against rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis 68:1528–1534
International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
Deuter CM, Kötter I, Wallace GR, Murray PI, Stübiger N, Zierhut M (2008) Behçet’s disease: ocular effects and treatment. Prog Retin Eye Res 27:111–136
BenEzra D, Cohen E (1986) Treatment and visual prognosis in Behcet’s disease. Br J Ophthalmol 70:589–592
Kural-Seyahi E, Fresko I, Seyahi N (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76
Ehrlich GE (1997) Vasculitis in Behçet’s disease. Int Rev Immunol 14:81–88
Matsumura N, Mizushima Y (1975) Leucocyte movement and colchicine treatment in Behcet’s disease. Lancet 2:813
Aktulga E, Altac M, Muftuoglu A, Ozyazgan Y, Pazarli H, Tuzun Y et al (1980) A double blind study of colchicine in Behcet’s disease. Haematologica 65:399–402
Thornhill MH, Baccaglini L, Theaker E, Pemberton MN (2007) A randomized, double-blind, placebo-controlled trial of pentoxifylline for the treatment of recurrent aphthous stomatitis. Arch Dermatol 143:463–470
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Appenzeller, S., Hazel, E. Pentoxifylline for the treatment of anterior uveitis in Behcet’s disease: possible alternative for TNF blockers. Rheumatol Int 31, 1511–1513 (2011). https://doi.org/10.1007/s00296-009-1305-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-1305-9